AD35702
Packsize | Purity | Availability | Price | Discounted Price | Quantity | |
---|---|---|---|---|---|---|
1g | 98% | in stock | $201.00 | $141.00 | - + | |
5g | 98% | in stock | $572.00 | $400.00 | - + | |
10g | 98% | in stock | $945.00 | $661.00 | - + | |
25g | 98% | in stock | $1,878.00 | $1,315.00 | - + |
*All products are for research use only and not intended for human or animal use.
*All prices are in USD.
Catalog Number: | AD35702 |
Chemical Name: | 4-(3,4-Difluorophenyl)-2-fluorobenzoic acid |
CAS Number: | 1179174-66-3 |
Molecular Formula: | C13H7F3O2 |
Molecular Weight: | 252.18868959999998 |
MDL Number: | MFCD12859451 |
SMILES: | OC(=O)c1ccc(cc1F)c1ccc(c(c1)F)F |
Complexity: | 311 |
Covalently-Bonded Unit Count: | 1 |
Heavy Atom Count: | 18 |
Hydrogen Bond Acceptor Count: | 5 |
Hydrogen Bond Donor Count: | 1 |
Rotatable Bond Count: | 2 |
XLogP3: | 3.4 |
When it comes to chemical synthesis, the compound 3,3',4'-Trifluoro-[1,1'-biphenyl]-4-carboxylic acid plays a crucial role as a versatile building block. Its unique structure and functional groups make it a valuable intermediate in the creation of various organic compounds. Due to the presence of the trifluoromethyl group and the carboxylic acid moiety, this compound can participate in a wide range of reactions, such as nucleophilic substitution, transition metal-catalyzed cross-coupling, and Friedel-Crafts reactions.One key application of 3,3',4'-Trifluoro-[1,1'-biphenyl]-4-carboxylic acid in chemical synthesis is its use as a building block for the preparation of pharmaceutical compounds. By utilizing the trifluoromethyl group as a fluorine source, chemists can introduce fluorine atoms into drug molecules to enhance their biological activity and metabolic stability. The carboxylic acid group can also serve as a handle for further derivatization, allowing for the introduction of various functional groups to fine-tune the properties of the final compound. This compound's versatility and reactivity make it a valuable tool for medicinal chemists striving to develop new drugs with improved pharmacological profiles.